Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |